Aamalaki, Amalaki, Amblabaum, Amla, Amla Berry, Aonla, Aovla, Arbre de Malacca, Arbre Myrobolan, Dhatriphala, Emblic, Emblica, Emblica officinalis, Emblic Myrobalan, Groseille à Maquereau Indienne, Groseille Indienne, Groseillier de Ceylan, Grosella de la India, Indian-Gooseberry, Mirobalano, Myrobalan Emblic, Mirobalanus embilica, Neli, Phyllanthus emblica, Yu Gan Zi.<br/><br/>
Overview InformationIndian gooseberry is a tree that grows in India, the Middle East, and some southeast Asian countries. Indian gooseberry has been used in Ayurvedic medicine for thousands of years. Today people still use the fruit of the tree to make medicine.
Indian gooseberry is taken by mouth for high cholesterol, "hardening of the arteries" (atherosclerosis), diabetes, pain and swelling of the pancreas (pancreatitis), cancer, upset stomach, eye problems, joint pain, diarrhea, bloody diarrhea (dysentery), osteoarthritis, obesity, "organ restoration", and for a skin disorder that causes unpigmented skin (vitiligo). It is also used to kill germs and reduce pain and swelling caused by the body's reaction to injury or illness (inflammation).
How does it work?Indian gooseberry seems to work by reducing total cholesterol levels, including the fatty acids called triglycerides, without affecting levels of the "good cholesterol" called high-density lipoprotein (HDL).
Uses & Effectiveness
Insufficient Evidence for
- High cholesterol. Some early research shows that taking Indian gooseberry for 4 weeks decreases low-density lipoprotein (LDL, or "bad") cholesterol in people with high cholesterol. Other early research shows that taking Indian gooseberry extract for 12 weeks decreases LDL cholesterol in obese people.
- Osteoarthritis. Research shows that taking two capsules of an Ayurvedic formula containing Indian gooseberry and several other ingredients three times daily for 24 weeks is as beneficial as taking glucosamine sulfate or the drug celecoxib for reducing pain in people with knee osteoarthritis.
- Skin disorder that causes unpigmented skin (vitiligo). Early research suggests that taking one tablet containing Indian gooseberry and other ingredients three times daily for 6 months along with standard treatment can increase skin repigmentation and reduce signs of inflammation better than standard treatment alone.
- Bloody diarrhea (dysentery).
- Eye problems.
- Hardening of the arteries (atherosclerosis).
- Joint pain.
- Swelling of the pancreas.
- Other conditions.
Side Effects & SafetyIndian gooseberry seems LIKELY SAFE for most people when consumed in amounts found in foods. Ayurvedic formulations containing Indian gooseberry have been linked to liver damage. But, it's not clear if taking Indian gooseberry alone might have these effects.
Special Precautions & Warnings:Pregnancy and breast-feeding: There is not enough reliable information about the safety of taking Indian gooseberry as medicine if you are pregnant or breast-feeding. Stay on the safe side and stick to food amounts.
Bleeding disorders: Indian gooseberry might increase the risk of bleeding or bruising in some people. If you have a bleeding disorder, use Indian gooseberry with caution.
Diabetes: Indian gooseberry might decrease blood sugar levels. Your diabetes medications might need to be adjusted by your healthcare provider.
Liver disease: In theory, taking Indian gooseberry with ginger, Tinospora cordifolia, and Indian frankincense might make liver function worse in people with liver disease. But it's not known if taking Indian gooseberry alone can have these effects.
Surgery: Indian gooseberry might increase the risk of bleeding during and after surgery. Stop taking Indian gooseberry at least 2 weeks before a scheduled surgery.
We currently have no information for INDIAN GOOSEBERRY Interactions.
The appropriate dose of Indian gooseberry depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for Indian gooseberry. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
- Al Rehaily, A. J., Al Howiriny, T. A., Al Sohaibani, M. O., and Rafatullah, S. Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats. Phytomedicine. 2002;9(6):515-522. View abstract.
- Bafna, P. A. and Balaraman, R. Anti-ulcer and anti-oxidant activity of pepticare, a herbomineral formulation. Phytomedicine. 2005;12(4):264-270. View abstract.
- Jose, J. K., Kuttan, G., and Kuttan, R. Antitumour activity of Emblica officinalis. J Ethnopharmacol. 2001;75(2-3):65-69. View abstract.
- Kaur, S., Michael, H., Arora, S., Harkonen, P. L., and Kumar, S. The in vitro cytotoxic and apoptotic activity of Triphala--an Indian herbal drug. J Ethnopharmacol. 2-10-2005;97(1):15-20. View abstract.
- Manjunatha, S., Jaryal, A. K., Bijlani, R. L., Sachdeva, U., and Gupta, S. K. Effect of Chyawanprash and vitamin C on glucose tolerance and lipoprotein profile. Indian J Physiol Pharmacol 2001;45(1):71-79. View abstract.
- Rege, N. N., Thatte, U. M., and Dahanukar, S. A. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother.Res 1999;13(4):275-291. View abstract.
- Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. View abstract.
- Scartezzini, P. and Speroni, E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol. 2000;71(1-2):23-43. View abstract.
- Shanmugasundaram, K. R., Seethapathy, P. G., and Shanmugasundaram, E. R. Anna Pavala Sindhooram--an antiatherosclerotic Indian drug. J.Ethnopharmacol. 1983;7(3):247-265. View abstract.
- Sharma, N., Trikha, P., Athar, M., and Raisuddin, S. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis. Drug Chem.Toxicol. 2000;23(3):477-484. View abstract.
- Srikumar, R., Parthasarathy, N. J., Shankar, E. M., Manikandan, S., Vijayakumar, R., Thangaraj, R., Vijayananth, K., Sheeladevi, R., and Rao, U. A. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother.Res. 2007;21(5):476-480. View abstract.
- Yokozawa, T., Kim, H. Y., Kim, H. J., Okubo, T., Chu, D. C., and Juneja, L. R. Amla (Emblica officinalis Gaertn.) prevents dyslipidaemia and oxidative stress in the ageing process. Br.J Nutr. 2007;97(6):1187-1195. View abstract.
- Anila L, Vijayalakshmi NR. Beneficial effects of flavonoids from Sesamum indicum, Emblica officinalis and Momordica charantia. Phytother Res 2000;14:592-5. View abstract.
- Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J Pharm Pharmacol 1993;45:581-4. View abstract.
- Bhattacharya A, Chatterjee A, Ghosal S, Bhattacharya SK. Antioxidant activity of active tannoid principles of Emblica officinalis (amla). Indian J Exp Biol 1999;37:676-80. View abstract.
- Chaudhuri, R. K. Emblica cascading antioxidant: a novel natural skin care ingredient. Skin Pharmacol Appl Skin Physiol 2002;15(5):374-380. View abstract.
- Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing 1996;202.
- Chopra A, Saluja M, Tillu G, Sarmukkaddam S, Venugopalan A, Narsimulu G, Handa R, Sumantran V, Raut A, Bichile L, Joshi K, Patwardhan B. Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology (Oxford) 2013;52(8):1408-17. View abstract.
- Colucci R, Dragoni F, Conti R, Pisaneschi L, Lazzeri L, Moretti S. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatol Ther. 2015;28(1):17-21. View abstract.
- Dev S. Ancient-modern concordance in Ayurvedic plants: some examples. Environ Health Perspect 1999;107:783-9. View abstract.
- Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579-85. View abstract.
- GRIN Taxonomy. Available at: http://www.ars-grin.gov/cgi-bin/npgs/html/tax_search.pl? (Accessed 27 February 2000).
- Hu JF. [Inhibitory effects of Phyllanthus emblica juice on formation of N-nitrosomorpholine in vitro and N-nitrosoproline in rat and human]. Chung Hua Yu Fang I Hsueh Tsa Chih 1990;24:132-5. View abstract.
- Ihantola-Vormisto A, Summanen J, Kankaanranta H, et al. Anti-inflammatory activity of extracts from leaves of Phyllanthus emblica. Planta Med 1997;63:518-24. View abstract.
- Jacob A, Pandey M, Kapoor S, Saroja R. Effect of the Indian gooseberry (amla) on serum cholesterol levels in men aged 35-55 years. Eur J Clin Nutr 1988;42:939-44. View abstract.
- Khanna S, Das A, Spieldenner J, Rink C, Roy S. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults. J Med Food. 2015;18(4):415-20. View abstract.